Japanese recommendation moves alogliptin closer to the market
04 March 2010
Ian Haydock
Please Login to read the full article.
04 March 2010
Ian Haydock
An advisory committee to Japan's
ministry of health, labour and welfare has recommended for approval
Takeda's oral antidiabetic, alogliptin. The positive opinion moves the DPP-4 inhibitor closer to what is likely to be its first market, following the delays in the US last year. Alogliptin...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Three month review delay in US sets Takeda's alogliptin further back in diabetes
- EC approval for BI/Lilly's one-dosage Trajenta for type 2 diabetes
- Takeda resubmits alogliptin NDAs in US as cardiovascular data become available
- Comparator choice scuppers BI/Lilly's Trajenta assessment in Germany
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
